Overall rank by patents
#40,878
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 12 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01R (MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES).
The verdict
Innovere holds 6 US patents across 12 technology areas, rank #40,878 of 50,000 tracked assignees.
Innovere Medical Inc. has been granted 6 US utility patents between 2020 and 2024, placing Innovere Medical Inc. at rank #40,878 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.0 claims per patent with primary concentration in G01R (MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES). As a Foreign Corporation, Innovere Medical Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Innovere sits between Innovative Health (6 patents, rank #40,874) and Inspekto A.m.v. Ltd. (6 patents, rank #40,882) - the closest US assignees by grant volume. The composite Innovation Score of 46.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Innovere Medical Inc.'s 23.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Innovere Medical Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
INNOVATIVE HEALTH
6 patents
INNOVATIVE MINING PRODUCTS (PTY) LTD
6 patents
INNOVATIVE PRECISION INSTRUMENTS LIMITED
6 patents
INNOVEERING, LLC
6 patents
INNOVID, INC.
6 patents
INOEX GMBH
6 patents
INPLAY, INC.
6 patents
INSPEKTO A.M.V. LTD.
6 patents
INNOVERE MEDICAL INC.
6 patents
What this shows Innovere holds 6 patents at rank #40,878, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #40,878 in granted patent volume.
Other assignees with the most granted patents in Innovere's primary technology class.
Innovere's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 2 | 33.3% |
| 2024 | 1 | 16.7% |
Top 12 of 12 technology areas
Overall rank by patents
#40,878
Across all tracked assignees
46.1 out of 100
How to use this portfolio
Innovere's 6 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.